What is the recommended starting dose of metformin for an adult patient with type 2 diabetes?

Metformin Starting Dose

For adults with type 2 diabetes and normal renal function (eGFR ≥60 mL/min/1.73 m²), start metformin immediate-release at 500 mg orally twice daily with meals, or alternatively 850 mg once daily with a meal. 1

Initial Dosing Strategy

The FDA-approved starting regimen provides two options 1:

• 500 mg twice daily with meals (preferred for minimizing gastrointestinal side effects)
• 850 mg once daily with a meal

Starting at the lower 500 mg dose helps minimize the most common adverse effects—gastrointestinal symptoms including nausea, diarrhea, and abdominal discomfort—which are the primary reasons patients discontinue metformin 2. The twice-daily regimen with meals is generally better tolerated than higher single doses 2.

Titration Schedule

After initiating therapy, increase the dose gradually based on glycemic control and tolerability 1:

• If starting with 500 mg twice daily: Increase by 500 mg weekly 3, 2, 1
• If starting with 850 mg once daily: Increase by 850 mg every 2 weeks 1
• Target dose: 1,000 mg twice daily (2,000 mg total daily) for most patients 2
• Maximum dose: 2,550 mg daily in divided doses, though doses above 2,000 mg may be better tolerated when given three times daily with meals 1

Extended-Release Formulation Alternative

For patients who prefer once-daily dosing or experience gastrointestinal intolerance with immediate-release metformin 2:

• Start with 500 mg once daily with the evening meal 2
• Titrate by 500 mg weekly as tolerated 2
• Maximum dose: 2,000 mg once daily 2

Extended-release metformin provides equivalent glycemic control to immediate-release formulations at comparable total daily doses, with potentially improved adherence due to once-daily administration 2, 4.

Renal Function Considerations Before Initiation

Check eGFR before starting metformin 3, 1:

• eGFR ≥60 mL/min/1.73 m²: Use standard dosing as above 3, 2
• eGFR 45-59 mL/min/1.73 m²: Can initiate at half the standard dose (start 500 mg once daily, titrate to maximum 1,000 mg daily) 3, 2
• eGFR 30-44 mL/min/1.73 m²: Initiate at half the standard dose (start 500 mg once daily, maximum 1,000 mg daily) 3, 2
• eGFR <30 mL/min/1.73 m²: Do not initiate metformin—it is contraindicated 3, 1

The FDA label specifically states that initiation in patients with eGFR 30-45 mL/min/1.73 m² is not recommended, though KDIGO guidelines suggest it can be initiated at reduced doses in this range 1, 3. In clinical practice, exercise caution and use the lower end of dosing if initiating in this eGFR range.

Monitoring Requirements

After initiation 3, 2:

• eGFR ≥60 mL/min/1.73 m²: Monitor renal function at least annually 3, 2
• eGFR <60 mL/min/1.73 m²: Monitor renal function every 3-6 months 3, 2
• Vitamin B12 levels: Consider checking periodically, especially after 4 years of therapy or if anemia or peripheral neuropathy develops 2

Common Pitfalls to Avoid

Starting at too high a dose is the most common error—this dramatically increases gastrointestinal side effects and leads to discontinuation 2. Always start low and titrate gradually.

Failing to check renal function before initiation can lead to lactic acidosis in patients with unrecognized renal impairment 1. This is a rare but potentially fatal complication.

Not educating patients about temporary discontinuation during acute illness, procedures with iodinated contrast (especially if eGFR 30-60 mL/min/1.73 m²), or conditions that may compromise renal function 2, 1.

Combination Therapy Considerations

Most patients with type 2 diabetes and eGFR ≥30 mL/min/1.73 m² benefit from treatment with both metformin and an SGLT2 inhibitor from the outset, particularly those with chronic kidney disease, heart failure, or established cardiovascular disease 3. However, metformin remains the appropriate starting point for initial monotherapy in patients without these comorbidities 3, 2.